Explore more publications!
The Africa Gazette
Got News to Share?

The Africa Gazette: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Africa Gazette.

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

December 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30 31

January 2026

Mo Tu We Th Fr Sa Su
1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31

Press releases published on December 10, 2025

Nigeria’s Remittance Inflows Reach USD 23 Billion in 2025, Marking the Highest Level in Five Years
December 10, 2025

Nigeria’s Remittance Inflows Reach USD 23 Billion in 2025, Marking the Highest Level in Five Years

Indeterminate EIN Presswire
Fortrea Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
December 10, 2025

Fortrea Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Major Drilling Announces Record Quarterly Revenue for its Second Quarter 2026
December 10, 2025

Major Drilling Announces Record Quarterly Revenue for its Second Quarter 2026

Indeterminate GlobeNewswire
Crinetics Pharmaceuticals Announces December 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
December 10, 2025

Crinetics Pharmaceuticals Announces December 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Clearmind Medicine Announces 1-for-40 Reverse Share Split
December 10, 2025

Clearmind Medicine Announces 1-for-40 Reverse Share Split

Indeterminate GlobeNewswire
Aardvark Therapeutics Announces First Patient Dosed in Australia in HERO Phase 3 Trial for Prader-Willi Syndrome
December 10, 2025

Aardvark Therapeutics Announces First Patient Dosed in Australia in HERO Phase 3 Trial for Prader-Willi Syndrome

Indeterminate GlobeNewswire
Rhythm Pharmaceuticals to Announce Preliminary Data from Exploratory Phase 2 Trial Evaluating Setmelanotide in Prader-Willi Syndrome
December 10, 2025

Rhythm Pharmaceuticals to Announce Preliminary Data from Exploratory Phase 2 Trial Evaluating Setmelanotide in Prader-Willi Syndrome

Indeterminate GlobeNewswire
CommsCloud’s new SIMs make borderless African IoT logistics a reality
December 10, 2025

CommsCloud’s new SIMs make borderless African IoT logistics a reality

Indeterminate EIN Presswire
AIM ImmunoTech Announces Release of the Next CEO Corner Segment
December 10, 2025

AIM ImmunoTech Announces Release of the Next CEO Corner Segment

Indeterminate GlobeNewswire
Veru to Report Fiscal Year 2025 Financial Results on December 17th
December 10, 2025

Veru to Report Fiscal Year 2025 Financial Results on December 17th

Indeterminate GlobeNewswire
Ajax Therapeutics Receives Orphan Drug Designation from the U.S. FDA for AJ1-11095 for the Treatment of Myelofibrosis
December 10, 2025

Ajax Therapeutics Receives Orphan Drug Designation from the U.S. FDA for AJ1-11095 for the Treatment of Myelofibrosis

Indeterminate GlobeNewswire
Copper Quest Completes Positive Alpine Due Diligence and Increases Private Placement
December 10, 2025

Copper Quest Completes Positive Alpine Due Diligence and Increases Private Placement

Indeterminate GlobeNewswire
Barinthus Bio Announces Update on Phase 1 AVALON Clinical Trial of VTP-1000 for the Treatment of Celiac Disease
December 10, 2025

Barinthus Bio Announces Update on Phase 1 AVALON Clinical Trial of VTP-1000 for the Treatment of Celiac Disease

Indeterminate GlobeNewswire
Fulcrum Therapeutics Announces Pricing of Upsized $175.0 Million Public Offering of Common Stock and Pre-Funded Warrants
December 10, 2025

Fulcrum Therapeutics Announces Pricing of Upsized $175.0 Million Public Offering of Common Stock and Pre-Funded Warrants

Indeterminate GlobeNewswire
Telix and Varian Announce Strategic Theranostics-EBRT Clinical Collaboration
December 10, 2025

Telix and Varian Announce Strategic Theranostics-EBRT Clinical Collaboration

Indeterminate GlobeNewswire
MEXC Research: 81% of Global Privacy Coin Trading Volume Originates from MENA, CIS, and Southeast Asia
December 10, 2025

MEXC Research: 81% of Global Privacy Coin Trading Volume Originates from MENA, CIS, and Southeast Asia

Indeterminate GlobeNewswire
Rakovina Therapeutics Announces Upcoming Webinar with Variational AI
December 10, 2025

Rakovina Therapeutics Announces Upcoming Webinar with Variational AI

Indeterminate GlobeNewswire
Global Uranium Corp. Announces Termination of NWA Option Agreement
December 10, 2025

Global Uranium Corp. Announces Termination of NWA Option Agreement

Indeterminate GlobeNewswire

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions